T1D patients have higher frequencies of circulating CD4+CXCR5+ICOS+Tfh cells and higher levels of IL-21 which positively correlates with an increase in plasmablasts, serum autoantibodies, and C-peptide levels (244–246). This evidence concerns the gene CXCR5 and type 1 diabetes mellitus.